PRIMETECH CORPORATION – Trademark Portfolio

Entity Type: 03

PRIMETECH CORPORATION holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IPRECIO. The owner is based in Toronto, Ontario.

5001 Yonge Street

Suite 302

Toronto, Ontario M2N 6P6 , CA

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PRIMETECH CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (3 filings)

Education; providing of training; entertainment; sporting and cultural activities

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does PRIMETECH CORPORATION have?

PRIMETECH CORPORATION has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 cancelled.

What trademark classes does PRIMETECH CORPORATION file in?

PRIMETECH CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 10 (Medical Apparatus). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are PRIMETECH CORPORATION's most well-known trademarks?

PRIMETECH CORPORATION's registered trademark portfolio includes well-known marks such as IPRECIO. These are among 2 currently registered trademarks in the portfolio.

What is PRIMETECH CORPORATION's trademark registration success rate?

PRIMETECH CORPORATION has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.